Is a complete SWX/CLTN research report available?

Question

Accepted Answer

No complete published report is available for swx/CLTN (SWX/CLTN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	292.2M
Revenue (ttm)	235.1M
Net income (ttm)	14.7M
EPS (ttm)	CHF 2.47
Shares out	6M
P/E (trailing)	19.8x
P/E (forward)	17.6x
Dividend	CHF 2.00 (4.09%)
Volume	12,146

Metric	Value
Country	Switzerland
Country code	CH
Employees	1,179.9
Employees Change	-71.1%
Employees Change Percent	-5.68
Enterprise value	CHF 318.5M
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Industry PE	44.52
Industry PE Fwd	22.56
Isin	CH0025343259
Last refreshed	2026-08-02
Market cap	CHF 292.2M
Price	CHF 48.9
Price currency	CHF
Rev Per Employee	199,194.92x
Sector	Healthcare
Sector PE	28.56
Sector PE Fwd	18.76
Sic	3843
Symbol	swx/CLTN
Website	https://www.coltene.com

Metric	Value
Earnings Yield	5.04%
EV Earnings	21.62x
EV/EBIT	16.56x
EV/EBITDA	11.91x
EV/FCF	21.92x
EV/Sales	1.35x
FCF yield	4.97%
Forward P/E	17.59x
P/B ratio	3.13x
P/E ratio	19.76x
P/S ratio	1.24x
PE Ratio10 Y	25.15x
PE Ratio3 Y	22.67x
PE Ratio5 Y	21.45x

Metric	Value
EBIT Margin	8.19%
EBITDA Margin	11.38%
FCF margin	6.18%
Gross margin	64.78%
Gross Profit	CHF 152.3M
Gross Profit Growth	-4.31%
Gross Profit Growth Q	-2.47%
Gross Profit Growth3 Y	-4.14%
Gross Profit Growth5 Y	-4.19%
Net Income	CHF 14.7M
Net Income Growth	2.91%
Net Income Growth Q	6.26%
Net Income Growth Years	0%
Net Income Growth3 Y	-14.89%
Net Income Growth5 Y	-10.83%
Pretax Margin	7.63%
Profit Margin	6.27%
Profit Per Employee	CHF 12,483
Profitable Quarters	CHF 43
Profitable Years	22
ROA	6.57
Roa5y	9.85
ROCE	19.48
ROE	16.04
Roe5y	20.28
ROIC	12.47
Roic5y	18.21

Metric	Value
Cagr10y	-0.31%
Cagr15y	4.64%
Cagr1y	-5.96%
Cagr20y	1.58%
Cagr3y	-8.04%
Cagr5y	-13.27%
Div CAGR10	-0.95%
Div CAGR3	-15.37%
Div CAGR5	-7.79%
EPS Growth	3.46
EPS Growth Q	6.57
EPS Growth Years	0
EPS Growth3 Y	-14.8
EPS Growth5 Y	-10.49
FCF Growth	51.84%
FCF Growth Q	-4.12%
FCF Growth3 Y	-18.17%
FCF Growth5 Y	-15.06%
OCF Growth	44.29%
OCF Growth Q	0.79%
OCF Growth10 Y	0.53%
OCF Growth3 Y	-15.48%
OCF Growth5 Y	-13.22%
Revenue Growth	-2.35x
Revenue Growth Q	-0.54x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.75x
Revenue Growth5 Y	-3.98x

SWX/CLTN (SWX/CLTN)

Coverage state: Market snapshot only — no published research

Generate the first SWX/CLTN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SWX/CLTN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/CLTN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SWX/CLTN

Frequently asked questions

Metric	Value
Asset Turnover	CHF 1.29
Assets	CHF 188.6M
Cash	CHF 26.7M
Current Assets	CHF 126.9M
Current Liabilities	CHF 77.5M
Debt	CHF 60M
Debt EBITDA	CHF 2.24
Debt Equity	CHF 0.64
Debt FCF	CHF 4.13
Equity	CHF 93.3M
Liabilities	CHF 95.3M
Long Term Assets	CHF 61.7M
Long Term Liabilities	CHF 17.9M
Net Cash	CHF -33.4M
Net Cash By Market Cap	CHF -11.41
Net Debt EBITDA	CHF 1.25
Net Debt Equity	CHF 0.36
Net Debt FCF	CHF 2.3
Tangible Book Value	CHF 86.9M
Tangible Book Value Per Share	CHF 14.58
WACC	7.35

Metric	Value
Current ratio	1.48
Inventory Turnover	1.41
Net Working Capital	CHF 76.2M
Quick ratio	0.85
Working Capital	CHF 42.8M
Working Capital Turnover	CHF 4.57

Metric	Value
Buyback Yield	0.58%
Dividend Growth	-20%
Dividend Growth Years	1%
Dividend per share	CHF 2
Dividend Years	20
Dividend Yield	4.09%
Ex Div Date	2026-04-23
Last Dividend	CHF 2
Payout Frequency	Annual
Payout Ratio	81.09%

Metric	Value
10Y total return	-3.1%
1Y total return	-5.96%
200-day SMA	50.62
3Y total return	-22.23%
50-day SMA	50.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-50.92%
All Time High	135
All Time High Change	-63.78%
All Time High Date	2021-08-24
All Time Low	24.8
All Time Low Change	97.18%
All Time Low Date	2012-06-15
ATR	1.59
Beta	0.84
Beta1y	1.28
Beta2y	0.98
Ch YTD	-8.94
High	51.4
High52	59
High52 Date	2026-02-18
High52ch	-17.12%
Low	48.9
Low52	42.6
Low52 Date	2025-11-06
Low52ch	14.79%
Ma50ch	-3.45%
Price vs 200-day SMA	-3.4%
RSI	41.77
RSI Monthly	43.29
RSI Weekly	45.97
Sharpe ratio	-0.32x
Sortino ratio	-0.26
Total Return	4.42%
Tr YTD	-5.26
Tr15y	97.4%
Tr1m	-4.49%
Tr1w	-2.1%
Tr3m	4.94%

Metric	Value
Analyst Count	3
Analyst Ratings	Hold
Operating Income	CHF 19.2M
Operating Income Growth	-10.1
Operating Income Growth Q	-2.79
Operating Income Growth3 Y	-16.19
Operating Income Growth5 Y	-19.1
Operating margin	8.18
Price target	CHF 58
Price Target Change	CHF 18.61

Metric	Value
Float	2,577,706%
Net Borrowing	9,000,000
Shares Insiders	22.07%
Shares Institutions	8.78%
Shares Out	5,975,391
Shares Qo Q	-1.08%
Shares Yo Y	-0.58%

Metric	Value
Average Volume	2,834.4x
Bv Per Share	15.62
CAPEX	CHF -5.2M
Ch10y	-31.51
Ch15y	16.43
Ch1m	-4.49
Ch1w	-2.1
Ch1y	-9.61
Ch20y	-41.01
Ch3m	4.94
Ch3y	-30.93
Ch5y	-59.59
Ch6m	-11.25
Change	-5.96%
Change From Open	-0.41
Close	52
Days Gap	-5.58
Depreciation Amortization	5,796,000
Dollar Volume	593,939.4
Earnings Date	2026-07-31
EBIT	CHF 19.2M
EBITDA	CHF 26.7M
EPS	CHF 2.47
F Score	5
FCF	CHF 14.5M
FCF EV Yield	4.56x
FCF Per Share	CHF 2.43
Financing CF	-2,971,000
Fiscal Year End	December
Founded	2,005
Graham Number	29.49178
Graham Upside	-39.69
Income Tax	CHF 3.2M
Investing CF	-6,559,000
Is Primary Listing	1
Last Earnings Date	2026-07-31
Last Report Date	2025-12-31
Lynch Fair Value	CHF 12.37
Lynch Upside	-74.7
Ma150	51.52
Ma150ch	-5.08%
Ma20	51.19
Ma20ch	-4.46%
Net CF	10,211,000
Next Earnings Date	2027-03-05
Open	49.1
P FCF Ratio	20.11
P OCF Ratio	14.8
Payment Date	2026-04-27
Position In Range	0
Ppne	43,738,000
Price Date	2026-07-31
Price EBITDA	CHF 10.93
Ptbv Ratio	3.36
Relative Volume	4.58x
Revenue	235,050,000x
Tax By Revenue	1.36x
Tax Rate	17.88%
Tr20y	36.89%
Tr6m	-7.67%
Volume	12,146